Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas.
about
Clinicopathological significance of expression of p-c-Jun, TCF4 and beta-Catenin in colorectal tumorsAnalysis of matrix metalloproteinase-7 expression in eutopic and ectopic endometrium samples from patients with different forms of endometriosis.Inferring proteolytic processes from mass spectrometry time series data using degradation graphs.Clinicopathological significance of stromal variables: angiogenesis, lymphangiogenesis, inflammatory infiltration, MMP and PINCH in colorectal carcinomas.Dimerumic acid inhibits SW620 cell invasion by attenuating H₂O₂-mediated MMP-7 expression via JNK/C-Jun and ERK/C-Fos activation in an AP-1-dependent manner.Prognostic significance of matrix metalloproteinase 7 immunohistochemical expression in colorectal cancer: a meta-analysis.Matrix metalloproteinase-7 as a surrogate marker predicts renal Wnt/β-catenin activity in CKD.NOX1 to NOX2 switch deactivates AMPK and induces invasive phenotype in colon cancer cells through overexpression of MMP-7.Peritoneal expression of Matrilysin helps identify early post-operative recurrence of colorectal cancer.Serum MMP7, MMP10 and MMP12 level as negative prognostic markers in colon cancer patients.High levels of serum VEGF and TIMP-1 are correlated with colon cancer liver metastasis and intrahepatic recurrence after liver resectionTumour budding at the deepest invasive margin correlates with lymph node metastasis in submucosal colorectal cancer detected by anticytokeratin antibody CAM5.2.Is there a genetic signature for liver metastasis in colorectal cancer?Genetic polymorphisms in the MMP-7 gene and breast cancer survivalClinicopathological and biological significance of cripto overexpression in human colon cancerRoles of LPA in ovarian cancer development and progression.Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget.Novel biomarkers for the prediction of metastasis in colorectal cancer.Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets.Profile of Expression of Genes Encoding Matrix Metallopeptidase 9 (MMP9), Matrix Metallopeptidase 28 (MMP28) and TIMP Metallopeptidase Inhibitor 1 (TIMP1) in Colorectal Cancer: Assessment of the Role in Diagnosis and Prognostication.Knockdown of MMP-7 inhibits cell proliferation and enhances sensitivity to 5-Fluorouracil and X-ray irradiation in colon cancer cells.Morphologic and molecular events at the invading edge of colorectal carcinomas.Immunohistochemical molecular markers as predictors of curability of endoscopically resected submucosal colorectal cancer.Matrix metalloproteinase-13 is regulated by toll-like receptor-9 in colorectal cancer cells and mediates cellular migration.MMP-7 as a prognostic marker in colorectal cancer.Syndecan-2 cytoplasmic domain up-regulates matrix metalloproteinase-7 expression via the protein kinase Cγ-mediated FAK/ERK signaling pathway in colon cancer.MMP7 Modulation by Short- and Long-term Radiotherapy in Patients with Rectal Cancer.Expression of matrix metalloproteinase-7 correlates with the invasion of T1 colorectal carcinoma.Protease probes that enable excimer signaling upon scission.Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential?Combined morphologic and molecular classification for predicting lymph node metastasis in early-stage colorectal adenocarcinoma.Identification of DNA methylation prognostic signature of acute myelocytic leukemia.
P2860
Q21260397-923DC9A7-E0FA-42C5-A870-1AEFE5C10BECQ33518252-41C57FF2-6BEE-4966-BA81-7A09B737EA56Q34344991-AA0F49BD-FFEE-46B9-B317-F596192BDC6FQ35104008-D021E4FE-8EA2-406E-85B5-653650032233Q35144719-543C09F3-6D30-45CB-BD88-BCF06E71AA8FQ35643502-C3E6823A-2872-4253-B724-B6AFAF117C08Q35715788-EF2A1516-42FC-467B-A3F8-53606B5319C1Q35785962-016FFC31-1643-45A1-8086-2A76A7854D1FQ35955331-9EAA36EA-EC19-4CCB-B127-4D6E05AD66B3Q36081008-E2DCD215-5C32-45C7-9252-D7BB1AED3EF9Q36099278-DD417669-3CDB-43F1-BEC6-3A7AA1833F53Q36613606-7A0B3E36-0012-44D6-B472-400FEB1B59A1Q36996320-29AA7978-DAC3-4157-A9A5-1ED8B35AFD46Q37003874-D421335C-AFFB-4B04-959F-84EB2C7F8D35Q37408842-0DB62313-A011-49AD-B6E0-6B0DAB451874Q37650618-698E1C28-B8E8-4FF2-ADD8-7B7E9F39F442Q37840946-29381985-F530-4F1E-97DD-C03ED4201F32Q38093253-8939BC2E-47FC-4ED6-8F72-B2F115015351Q38107451-F5843146-E44B-4BED-BEBE-C1126CA42559Q38908279-E0A1A142-F207-480A-AEE9-F5FEFEC6D8BEQ39255564-08B9B75E-CF69-44FF-8888-DCF190C50E7CQ40795997-9D3ADE20-544E-42BF-93FE-DC64B037301BQ41852083-E8DA09AC-3EA8-4B1D-B8A6-3314BAA6D563Q42259293-543A9697-C323-4B8B-8011-DAD75B3DFDF6Q45177603-9D5C2067-361C-422A-BF68-28BF1792E3C9Q47933451-EE178720-F188-4916-9B2A-50420A37892EQ49594019-1697AB8C-225E-43DF-B89D-25B1B4FDF437Q49874920-CB8A26D0-18EE-4E90-9554-E45FBA35E4A8Q52873874-B187900B-F0D1-4BFD-803B-3CCC4F58DBD4Q53340431-8F0BE449-3C2A-461E-A020-047756A34FE8Q54375519-1207458D-98AA-49AD-9DCE-49C170ECEE9AQ55439053-32377C00-1B71-4BB9-B6CD-56F42CEF6307
P2860
Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Matrilysin (MMP-7) as a signif ...... nvasive colorectal carcinomas.
@ast
Matrilysin (MMP-7) as a signif ...... nvasive colorectal carcinomas.
@en
type
label
Matrilysin (MMP-7) as a signif ...... nvasive colorectal carcinomas.
@ast
Matrilysin (MMP-7) as a signif ...... nvasive colorectal carcinomas.
@en
prefLabel
Matrilysin (MMP-7) as a signif ...... nvasive colorectal carcinomas.
@ast
Matrilysin (MMP-7) as a signif ...... nvasive colorectal carcinomas.
@en
P2093
P2860
P356
P1476
Matrilysin (MMP-7) as a signif ...... nvasive colorectal carcinomas.
@en
P2093
Matsuoka H
Sakamoto A
Sugiyama M
P2860
P2888
P304
P356
10.1054/BJOC.2001.1790
P407
P577
2001-05-01T00:00:00Z
P5875
P6179
1027173467